Veterinary Medicines

Lactolyte Pulver zur Herstellung einer Lösung zum Einnehmen

Not authorised
  • Sodium chloride
  • SODIUM ACETATE ANHYDROUS
  • Sodium propionate
  • WHEY
  • Potassium chloride
  • MAGNESIUM CHLORIDE ANHYDROUS
  • Potassium dihydrogen phosphate
Download as PDF

Product identification

Medicine name:
Lactolyte Pulver zur Herstellung einer Lösung zum Einnehmen
Lactolyte Poudre pour solution buvable
Lactolyte Poeder voor drank
Active substance:
  • Sodium chloride
  • SODIUM ACETATE ANHYDROUS
  • Sodium propionate
  • WHEY
  • Potassium chloride
  • MAGNESIUM CHLORIDE ANHYDROUS
  • Potassium dihydrogen phosphate
Target species:
  • Cattle (calf)
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Sodium chloride
    2.92
    gram(s)
    /
    90.00
    gram(s)
  • SODIUM ACETATE ANHYDROUS
    4.90
    gram(s)
    /
    90.00
    gram(s)
  • Sodium propionate
    1.92
    gram(s)
    /
    90.00
    gram(s)
  • WHEY
    76.88
    gram(s)
    /
    90.00
    gram(s)
  • Potassium chloride
    0.74
    gram(s)
    /
    90.00
    gram(s)
  • MAGNESIUM CHLORIDE ANHYDROUS
    0.38
    gram(s)
    /
    90.00
    gram(s)
  • Potassium dihydrogen phosphate
    1.36
    gram(s)
    /
    90.00
    gram(s)
Pharmaceutical form:
  • Powder for oral solution
Withdrawal period by route of administration:
  • Oral use
    • Cattle (calf)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA07CQ01
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Belgium
Package description:
  • Lactolyte Powder for oral solution Barrel of 4.5 kg
  • Lactolyte Powder for oral solution Jar of 900 g
  • Lactolyte Powder for oral solution Box of 40 sachets of 90g
  • Lactolyte Powder for oral solution Box of 8 sachets of 90g

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • Virbac
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 10/02/2022
Download
French (PDF)
Published on: 10/02/2022
Download
German (PDF)
Published on: 10/02/2022
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 10/02/2022
Download
French (PDF)
Published on: 10/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."